Tuesday April 25, 2017 02:12

Heathcare Press Release : 14 Feb 2017

Hearing Date of Thalidomide Lawsuit in Germany announced Heathcare—14 Feb 17

60 years after the market launch of Contergan (active ingredient: thalidomide), the greatest pharmaceutical scandal in the Federal Republic of Germany continues to boil. A lawsuit will be heard in the Bonn Regional Court at 12:00 hrs on 15.2.2017 that is

Janssen Announces Two-drug Combination of Dolutegravir and Rilpivirine Demonstrates Efficacy in Heathcare—14 Feb 17

- First Detailed Results from SWORD Clinical Trial Program Show Investigational Two-drug Combination as Effective as Three- or Four-drug Regimens as Maintenance Therapy in Patients who have Already Achieved Viral Suppression Janssen Sciences Ireland UC

European Commission Approves Once-Daily Olumiant Tablets for Treatment of Adults with Heathcare—14 Feb 17

Baricitinib, marketed as Olumiant, is the first JAK inhibitor approved to treat RA in the EU Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) announced today that the European Commission has granted marketing authorisation for